Dean Sheppard
Internal Medicine · San Francisco, CANPI 1649286899
Payments from drug & device makers
Across 32 payments — averaging $23,051 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$322K
- AbbVie$264K
- Genentech, Inc.$75K
- Genentech USA, Inc.$44K
- Amgen$29K
- Gilead$4K
What the payments were for
- Consulting fees$155,71099%
- Travel & lodging$1,0991%
- Food & beverage$4110%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 3 | $322,055 |
| AbbVie | 5 | $264,136 |
| Genentech, Inc. | 8 | $74,500 |
| Genentech USA, Inc. | 3 | $44,000 |
| Amgen | 11 | $29,049 |
| Gilead | 2 | $3,895 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Non-Covered Product$22,500
How this compares
$737,636 in reported general payments places this provider in the 95th percentile of 13,581 internal medicine providers in California.
Other internal medicine in San Francisco
- Rahul AggarwalSan Francisco$24M
- Thomas MartinSan Francisco$13.7M
- Peter HuntSan Francisco$9.8M
- Diane HavlirSan Francisco$8.4M
- Sandy WongSan Francisco$6.6M
- Nina ShahSan Francisco$5.4M
- Katy TsaiSan Francisco$3.8M
- Riley BoveSan Francisco$3.6M
- Jacob LalezariSan Francisco$3.3M
- Flavio VincentiSan Francisco$2.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.